Skip to main content

NATIXIS

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1274981 PARIS, I0

Position in TMO

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$32,732,457
+$585,151 QoQ
Shares Held
66,593
+20.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Sep 30, 2022
CallValue
$2,535
CallShares
5
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

NATIXIS holds $131,242,925 across 14 Diagnostics & Research names. TMO ranks #2 (24.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 TMO
Thermo Fisher Scientific Inc.
This page
66,593 $32,732,457

All Filings in TMO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $32,732,457 66,593
2025-12-31 $32,147,306 55,479
2025-09-30 $88,479,288 182,424
2025-06-30 $23,428,695 57,783
2025-03-31 $12,632,571 25,387
2024-12-31 $17,838,686 34,290
2024-09-30 $37,176,675 60,101
2024-06-30 $11,406,731 20,627
2024-03-31 $830,549 1,429
2023-12-31 $95,645,172 180,194
2023-09-30 $15,987,379 31,585
2023-06-30 $20,744,258 39,759
2023-03-31 $9,129,700 15,840
2022-12-31 $48,791,683 88,601
2022-09-30 $2,535 5
2022-09-30 $35,503,299 70,000
2022-06-30 $50,635,325 93,203
2022-06-30 $1,086 2
2022-03-31 $68,644,751 116,219
2021-12-31 $57,185,803 85,705
2021-09-30 $61,432,257 107,525
2021-03-31 $66,834,112 146,444
2020-12-31 $86,456,220 185,616
2020-09-30 $39,189,314 88,760
2020-06-30 $8,319,326 22,960
2020-03-31 $36,035,350 127,064